Treatment with apolipoprotein A1 protects mice against doxorubicin-induced cardiotoxicity in a scavenger receptor class B, type I-dependent manner.
Durham KK, Kluck G, Mak KC, Deng YD, Trigatti BL.
Durham KK, et al. Among authors: trigatti bl.
Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1447-H1457. doi: 10.1152/ajpheart.00432.2018. Epub 2019 Apr 19.
Am J Physiol Heart Circ Physiol. 2019.
PMID: 31002281
Free article.
We previously showed that treating cultured cardiomyocytes with human high-density lipoprotein in vitro or transgenic overexpression of human apolipoprotein A1, its main structural protein, protects against doxorubicin-induced cardiomyocyte apoptosis in a manner dependent on the …
We previously showed that treating cultured cardiomyocytes with human high-density lipoprotein in vitro or transgenic overexpression of huma …